CCTR yields 200000000.00% · PFE yields 6.20%● Live data
📍 CCTR pulled ahead of the other in Year 1
Combined, CCTR + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CCTR + PFE for your $10,000?
China Crescent Enterprises, Inc., through its subsidiaries, provides information technology products and services, and systems integration services in the People's Republic of China. It offers consulting, development, implementation, and maintenance services for technology systems, which include software and hardware peripherals for computing, communication, and data exchanges related to general business application, as well as specialty fields of medical, security, military, and homeland defense applications. The company also involves in the prototype development of security systems and original equipment manufacturer sourcing for the production of hardware. In addition, it engages in the resale of IT products, including notebook and desktop computers, printers, servers, network equipment, as well as operating systems, database, middleware, and application software. Further, the company manufactures wireless communication terminals, including GSM, GSM/GPRS modules, GPS modules, GPS trackers, and personal navigation devices. It has a strategic partnership with Gaozhi Science and Technology Development, LTD. to develop and distribute high technology products and services. The company was formerly known as NewMarket China, Inc. and changed its name to China Crescent Enterprises, Inc. in June 2008. China Crescent Enterprises, Inc. is headquartered in Dallas, Texas. China Crescent Enterprises, Inc. is a subsidiary of NewMarket Technology, Inc.
Full CCTR Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.